GENEVA, March 24 -- GILEAD SCIENCES, INC. (333 Lakeside DriveFoster City, California 94404) filed a patent application (PCT/US2025/045802) for "OBELDESIVIR FOR THE TREATMENT OF A CORONAVIRUS INFECTION" on Sep 10, 2025. With publication no. WO/2026/060034, the details related to the patent application was published on Mar 19, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): OSINUSI, Anuoluwapo (c/o Gilead Sciences, Inc.333 Lakeside DriveFoster City, California 94404)
Abstract: The present disclosure relates to methods for treating coronavirus infections.
For more information:https://patentsc...